Wang Y - Search Results

1

Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.

Takahashi H, Wang Y, Grainger DW. Takahashi H, et al. Among authors: wang y. J Control Release. 2010 Nov 1;147(3):400-7. doi: 10.1016/j.jconrel.2010.08.019. Epub 2010 Aug 19. J Control Release. 2010. PMID: 20727922 Free PMC article.

2

siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption.

Wang Y, Grainger DW. Wang Y, et al. Pharm Res. 2010 Jul;27(7):1273-84. doi: 10.1007/s11095-010-0099-5. Epub 2010 Mar 24. Pharm Res. 2010. PMID: 20333451 Free PMC article.

3

RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Wang Y, Grainger DW. Wang Y, et al. Adv Drug Deliv Rev. 2012 Sep;64(12):1341-57. doi: 10.1016/j.addr.2011.09.002. Epub 2011 Sep 10. Adv Drug Deliv Rev. 2012. PMID: 21945356 Free PMC article. Review.

4

Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials.

Wang Y, Tran KK, Shen H, Grainger DW. Wang Y, et al. Biomaterials. 2012 Nov;33(33):8540-7. doi: 10.1016/j.biomaterials.2012.07.039. Epub 2012 Sep 3. Biomaterials. 2012. PMID: 22951320 Free PMC article.

5

Developing siRNA therapies to address osteoporosis.

Wang Y, Grainger DW. Wang Y, et al. Ther Deliv. 2013 Oct;4(10):1239-46. doi: 10.4155/tde.13.85. Ther Deliv. 2013. PMID: 24116909 Free PMC article. Review.

6

Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures.

Wang Y, Panasiuk A, Grainger DW. Wang Y, et al. Mol Pharm. 2011 Aug 1;8(4):1016-24. doi: 10.1021/mp100374n. Epub 2011 Jan 21. Mol Pharm. 2011. PMID: 21186792 Free PMC article.

7

A cell-based pharmacokinetics assay for evaluating tubulin-binding drugs.

Wang Y, Liu J, Zhang J, Wang L, Chan J, Wang H, Jin Y, Yu L, Grainger DW, Ying W. Wang Y, et al. Among authors: wang h, wang l. Int J Med Sci. 2014 Mar 18;11(5):479-87. doi: 10.7150/ijms.8340. eCollection 2014. Int J Med Sci. 2014. PMID: 24688312 Free PMC article.

8

Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.

Wang Y, Grainger DW. Wang Y, et al. Adv Drug Deliv Rev. 2019 Nov-Dec;151-152:56-71. doi: 10.1016/j.addr.2019.03.003. Epub 2019 Mar 18. Adv Drug Deliv Rev. 2019. PMID: 30898571 Review.

9

Effect of molecular weight of PGG-paclitaxel conjugates on in vitro and in vivo efficacy.

Yang D, Liu X, Jiang X, Liu Y, Ying W, Wang H, Bai H, Taylor WD, Wang Y, Clamme JP, Co E, Chivukula P, Tsang KY, Jin Y, Yu L. Yang D, et al. Among authors: wang h, wang y. J Control Release. 2012 Jul 10;161(1):124-31. doi: 10.1016/j.jconrel.2012.04.010. Epub 2012 Apr 12. J Control Release. 2012. PMID: 22521595

10

Mining Silent Biosynthetic Gene Clusters for Natural Products in Filamentous Fungi.

Mao XM, Wang Y. Mao XM, et al. Among authors: wang y. Chem Biodivers. 2025 Jan 16:e202402715. doi: 10.1002/cbdv.202402715. Online ahead of print. Chem Biodivers. 2025. PMID: 39817799

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298,357 results

Search Page

Filters